Literature DB >> 4819268

Radiation therapy in the management of epidermoid carcinoma of the anal region.

J Papillon.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4819268     DOI: 10.1007/bf02588101

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


× No keyword cloud information.
  7 in total

1.  Management of anal epidermoid carcinoma--an evaluation of treatment results in two population-based series.

Authors:  S Goldman; B Glimelius; U Glas; G Lundell; L Påhlman; E Ståhle
Journal:  Int J Colorectal Dis       Date:  1989-12       Impact factor: 2.571

2.  Radiotherapy with or without chemotherapy in the treatment of anal cancer: 20-year experience from a single institute.

Authors:  K Fakhrian; T Sauer; S Klemm; C Bayer; B Haller; M Molls; H Geinitz
Journal:  Strahlenther Onkol       Date:  2012-11-15       Impact factor: 3.621

3.  Recurrent squamous cell carcinoma of the anal canal. Predictors of initial treatment failure and results of salvage therapy.

Authors:  W E Longo; A M Vernava; T P Wade; M A Coplin; K S Virgo; F E Johnson
Journal:  Ann Surg       Date:  1994-07       Impact factor: 12.969

4.  Carcinoma of the anus.

Authors:  O H Beahrs; S M Wilson
Journal:  Ann Surg       Date:  1976-10       Impact factor: 12.969

5.  Staging anal cancer: prospective comparison of transanal endoscopic ultrasound and magnetic resonance imaging.

Authors:  S D Otto; L Lee; H J Buhr; B Frericks; S Höcht; A J Kroesen
Journal:  J Gastrointest Surg       Date:  2009-04-14       Impact factor: 3.452

6.  Anal cancer: the case for earlier diagnosis.

Authors:  A T Edwards; L C Morus; M E Foster; G H Griffith
Journal:  J R Soc Med       Date:  1991-07       Impact factor: 18.000

7.  Assessment of long-term quality of life in patients with anal carcinomas treated by radiotherapy with or without chemotherapy.

Authors:  A S Allal; M A Sprangers; F Laurencet; M A Reymond; J M Kurtz
Journal:  Br J Cancer       Date:  1999-07       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.